Myocardial Infarction Workup: Approach Considerations, Cardiac Biomarkers/ Enzymes, Troponin Levels
Corporate Medical Policy
IJMS | Free Full-Text | Diagnostic Roles of Postmortem cTn I and cTn T in Cardiac Death with Special Regard to Myocardial Infarction: A Systematic Literature Review and Meta-Analysis
ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison | Journal of the American College of Cardiology
Unstable Angina Workup: Approach Considerations, Basic Blood Studies, Cardiac Biomarkers
Cardiac Marker - an overview | ScienceDirect Topics
Cardiac marker - Wikipedia
VIDAS ® Troponin I Ultra - Understanding Your Concerns | bioMérieux Clinical Diagnostics
Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide | Biomarkers in Medicine
Frontiers | A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases | Metabolic Syndrome and Related Disorders
Biomarkers in Acute Cardiac Disease: The Present and the Future - ScienceDirect
Cardiac biomarkers: a contemporary status report | Nature Reviews Cardiology
High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain | Circulation
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19 | Hypertension
Diagnostics | Free Full-Text | Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction—Promises and Challenges
Cardiac biomarkers and detection methods for myocardial infarction | SpringerLink
Acute Coronary Syndrome Workup: Approach Considerations, Electrocardiography, Measurement of CK-MB Levels
Heart Failure Biomarkers in COVID-19 - American College of Cardiology
Intermittent fasting may protect the heart by controlling inflammation | American Heart Association
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy
Cardiac Biomarkers for Myocardial Infarction I. Policy Description II. Related Policies III. Indications and/or Limitations of C
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease | Scientific Reports
